Takeda (TSE:4502/NYSE:TAK) today announced that it has entered into an exclusive licensing agreement with Keros Therapeutics, ...

Takeda Pharmaceutical Company Limited (NYSE:TAK) entered into an exclusive licensing agreement with Keros Therapeutics, Inc. ...

The outlay, plus up to $1.1 billion in milestones, has secured Takeda ex-China rights to a molecule that could compete with ...

Study finds annual healthcare costs per patient are significantly higher than previously described– HHT costs are higher than other ...

Japanese pharma major Takeda has agreed an exclusive licensing agreement with US pharma Keros Therapeutics (Nasdaq: KROS) to ...

Sites in Los Angeles and near San Francisco California are enrolling people with severe SCD for a trial to test a gene ...

Adaptimmune is a fully integrated cell therapy company working to redefine how cancer is treated. With its unique engineered ...

Don't be alarmed by the red meat juice in your raw steak packet. While it may look like blood, there's another reason why raw ...

And God blessed the seventh day and declared it holy—having ceased on it from all the work of creation that God […] ...

Keros Therapeutics, Inc. has announced a significant global license agreement with Takeda for the advancement of elritercept, ...

Munakka, also known as black raisins, is a powerhouse of nutrition that has been cherished in traditional medicine and ...

In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity ...